The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase III trial of lenvatinib (LEN) vs sorafenib (SOR) in first-line treatment of patients (pts) with unresectable hepatocellular carcinoma (uHCC).
 
Ann-Lii Cheng
Consulting or Advisory Role - Bayer Schering Pharma; Bristol-Myers Squibb; Merck Serono; Novartis; ONXEO
Speakers' Bureau - Novartis
Research Funding - Sanofi
 
Richard S. Finn
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Merck; Novartis; Pfizer
Research Funding - Pfizer (Inst)
 
Shukui Qin
No Relationships to Disclose
 
Kwang-Hyub Han
Consulting or Advisory Role - Eisai
Research Funding - Eisai (Inst)
Travel, Accommodations, Expenses - Bayer
 
Kenji Ikeda
Honoraria - Dainippon Sumitomo Pharma; Eisai
 
Fabio Piscaglia
Consulting or Advisory Role - Bayer; Eisai
Speakers' Bureau - Bayer; Bracco Diagnostics; Meda Pharmaceuticals
Research Funding - Esaote (Inst)
 
Ari David Baron
Speakers' Bureau - Bristol-Myers Squibb; Genentech; Lilly; Merck
 
Joong-Won Park
Honoraria - Bayer; Bristol-Myers Squibb; Ono Pharmaceutical
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Eisai; Merck; Ono Pharmaceutical
 
Guohong Han
No Relationships to Disclose
 
Jacek Jassem
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim
Speakers' Bureau - Roche
Travel, Accommodations, Expenses - Roche
 
Jean-Frédéric Blanc
Honoraria - Bayer; Merrimack
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly; Novartis
Travel, Accommodations, Expenses - Bayer
 
Arndt Vogel
Honoraria - Amgen; Bayer; Bristol-Myers Squibb; Delcath Systems; Lilly; MSD; Novartis; Roche; Sanofi
Consulting or Advisory Role - Amgen; Baxalta; Bayer; Delcath Systems; Lilly; Novartis; Roche
Research Funding - Novartis
Travel, Accommodations, Expenses - Bayer; Ipsen; Roche
 
Dmitry Komov
No Relationships to Disclose
 
T.R. Jeffry Evans
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Baxter; Bristol-Myers Squibb; Celgene; Eisai; Karus Therapeutics
Speakers' Bureau - Bristol-Myers Squibb; Celgene
Research Funding - AstraZeneca (Inst); Basilea (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Immunocore (Inst); Lilly (Inst); Merck (Inst); Roche (Inst); Vertex (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Carlos López-López
Consulting or Advisory Role - Bayer; Eisai; Novartis
Research Funding - Bayer; Daiichi Sankyo; Eisai; Novartis
 
Corina E Dutcus
Employment - Eisai
Leadership - Eisai
Research Funding - Eisai (Inst)
 
Min Ren
Employment - Eisai
 
Silvija Kraljevic
Employment - Eisai
 
Toshiyuki Tamai
Employment - Eisai
Stock and Other Ownership Interests - Eisai
 
Masatoshi Kudo
Honoraria - Ajinomoto; Bayer; Eisai; MSD
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Chugai Pharma; Kowa; MSD; Taiho Pharmaceutical
Research Funding - Abbvie; Bayer; Chugai Pharma; Daiichi Sankyo; Eisai; MSD; Otsuka; Sumitomo Dainippon; Taiho Pharmaceutical; Takeda